Number: CTSU E1305 Principal Investigator: Adkins, Douglas
Title: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab In Patients with Recurrent or Metastatic Head and Neck Cancer
Phase: III Disease Site: Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
Contact: 800-600-3606 or

You may be asked to participate in this study if you have head and neck cancer for which there is no curative therapy.

The purpose of this study is to compare the effects (good and bad) of the addition of a drug called bevacizumab to the standard chemotherapy to see which works better. We will determine if the combination of standard chemotherapy (cisplatin and docetaxel or cisplatin and 5-FU) and bevacizumab can increase the effectiveness of treatment for head and neck cancer. We will determine if adding bevacizumab to standard therapy produces results that are better than those we would ordinarily expect. Currently, we do not know whether using bevacizumab will be effective. This is a subject of this study.

About 400 people will take part in this study.
More Information: Link
Internal Protocol Documents (requires Siteman administrative database password)